Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 01, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification.
Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2026
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 24, 2025
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Journal: JCO precision oncology
Published: September 02, 2025
Claudin 18.2 and Other Therapeutic Biomarkers in Gastric and Gastroesophageal Junction Adenocarcinomas.
Journal: The American journal of surgical pathology
Published: August 27, 2025
Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 10, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.
Journal: Science (New York, N.Y.)
Published: May 08, 2025
Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer.
Journal: Cancer cell
Published: April 14, 2025
Quality indicators and patient outcome measures for palliative care in cancer patients: a systematic review.
Journal: Ecancermedicalscience
Published: February 27, 2025
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2025
Last Updated: 09/26/2026